Wilmington, DE -- (SBWIRE) -- 12/17/2013 -- -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Real Goods Solar, Inc. (NASDAQ:RSOL) and Gilead Sciences Inc. (NASDAQ:GILD).
Real Goods Solar, Inc. (NASDAQ:RSOL) operates as a residential and commercial solar energy engineering, procurement, and construction company in the United States closed down in its previous session (-3.12%) on 3,644,386 shares traded. Real Goods Solar, Inc. (NASDAQ:RSOL) is currently down (-72.11%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Real Goods Solar, Inc. (NASDAQ:RSOL)
Gilead Sciences Inc. (NASDAQ:GILD) a biopharmaceutical company that discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia closed up in its previous session (+0.03%) on 12,025,395 shares traded after Gilead Sciences, Inc. announced that Health Canada has issued a Notice of Compliance for Sovaldi 400 mg tablets, a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C infection. Gilead Sciences Inc. (NASDAQ:GILD) is currently up (+106.95%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Gilead Sciences Inc. (NASDAQ:GILD)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report